Cite
APA Citation
Wymann, S., Mischnik, M., Leong, D., Ghosh, S., Tan, X., Cao, H., Kuehnemuth, B., Powers, G. A., Halder, P., de Souza, M. J., James, H. S., Tomasetig, V., Lind, H., Rossato, P., Owczarek, C. M., Ow, S. Y., Dower, S. K., Baz Morelli, A., Rowe, T., & Hardy, M. P. (2022). sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo. Biochemical journal, 479(9), 1007–1030. http://access.bl.uk/ark:/81055/vdc_100156449425.0x00002c